Document:

Consulting Agr - Goldberg

    Exhibit
      10.5

    

    ACCELERIZE
      NEW MEDIA, INC.

    CONSULTING
      AGREEMENT

     

    This
      consulting agreement is by
      and
      between Accelerize New Media, Inc., a Delaware corporation with headquarters
      at
6477
      HWY
      93 South, Suite 303, Whitefish, MT 59937
      (the
“Company”),
      and
      Facility Consulting, LLC, a Nevada
      LLC (the “Provider”), and
      will
      be
      effective as of January 1, 2007 (the “Effective
      Date”):

    

    1.
      Consultant.

    

    (a)
      The
      Provider agrees to provide Dan Goldberg (the “Consultant”) as a consultant to
      the Company to perform the provisions of this agreement on the terms and
      conditions set forth below. The Provider understands that the Company has
      purchased the business of The Debt Reduction Group, LLC (“DRG”)
      and
      intends to continue and to grow DRG’s internet marketing business (the
“DRG
      Business”)
      as
      well as all other aspects of the Company’s business.  As
      a 50%
      owner of DRG, the Consultant provided services to the DRG Business and, pursuant
      to this Agreement, will provide similar services as well as other consulting
      services to the Company in connection with the integration of the DRG Business
      as well as in connection with the operation of the business of the Company
      (the
“Services”).
      The
      Services will include responsibility for all marketing of the DRG Business
      and
      advising on the websites, edgar sales and marketing of the Company’s properties
      including executivedisclosure.com, secfilings.com or "Investor Services".

    

    (b)
      So
      long as the Consultant is engaged in the Services on a full time basis, he
      will
      devote sufficient business time, labor, skill, attention and work to the best
      of
      his ability to perform his duties hereunder in a manner which will faithfully
      and diligently further the business and interests of the Company. During the
      term of his consultancy, the Consultant will not directly or indirectly pursue
      any other business activity which
      unreasonably interferes
      with the
      performance of his duties and responsibilities hereunder; provided,
      however,
      that
      the Consultant may pursue other business interests and serve on civic or other
      charitable boards or committees and manage personal investments, so long as
      such
      activities do not interfere in
      any
      material respect
      with the
      performance of his duties and responsibilities hereunder; provided
      further
      that
      this Section 1(b) shall not apply when the Consultant is consulting on a
“Part-Time”
basis
      (as defined below).

    

    2.
      Representations
      and Warranties.
      The
      Provider and the Consultant represent and warrant that the Consultant does
      not
      have and will not enter into (a) obligations with any third parties that
      interfere with the satisfaction of his obligations to the Company as provided
      hereunder and (b) any arrangements that might impact the performance of his
      Services or the ownership of any intellectual property that he may develop
      during the Term.

    

    3.
      Compensation.
      In
      consideration for the provision of the Consultant to perform the Services for
      the Company, the Provider will receive (a) One Hundred Twenty Thousand Dollars
      ($120,000) per year so long as the Consultant is engaged in the Services on
      a
      full time basis, (b) the Company will reimburse the Consultant for the cost
      of
      his health insurance premium as set forth on Exhibit
      A
      and (c)
      the Company will reimburse the Consultant for the cost of monthly cell phone
      charges for calls relating to the Company’s business or the provision of the
      Services hereunder. When the provision of the Services becomes Part-Time,
      payments owing hereunder shall be reduced to $75,000 per year and the Company
      shall no longer be responsible for the payment of the Consultant’s health
      insurance premium or cell phone charges. For the purposes of this Section 3,
      the
      Consultant shall be deemed to be engaged “Part-Time”
if
      the
      President or the Consultant notifies the other that the status has been reduced
      to Part-Time or requests that the Services provided hereunder be reduced or
      revised. If the Consultant disagrees with a determination that he be engaged
      Part-Time, the parties agree to work together to determine how he can fulfill
      his obligations under this Agreement on a full time basis. Notwithstanding
      that
      the Services are rendered on a Part-Time basis, the Consultant shall remain
      obligated to perform all the Services required of him hereunder (taking into
      account any reduction or revision of the Services agreed upon by the
      parties).

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

    Stock
      Option Plan.
      The
      Consultant shall, to the extent he is otherwise eligible, be entitled to
      participate in the Company’s stock option plan; provided that any grant of
      options shall be subject to vesting and other terms and conditions as may be
      determined by the Board of Directors of the Company. Upon execution of this
      agreement, the Consultant shall be granted a non-qualified stock option (an
      “NSO”)
      to
      purchase 400,000 shares of the Company’s common stock subject to the terms and
      conditions of the option agreement between the Company and you relating to
      such
      option of even date herewith (the “NSO
      Agreement”).

    

    5.
      Term
      and Termination.
      The
      term
      of this Agreement shall be for three (3) years from the Effective Date (the
      “Term”);provided that
      you
      shall have the option to renew for an additional 2 year term by giving written
      notice to the Company of your intention to do so 60 days before the expiration
      of the Term. If this option is exercised the word “Term” shall include such
      additional 2 year period. You and the Company may also elect to continue your
      consulting after expiration of the Term or the renewal period on such terms
      and
      conditions of consulting as are mutually agreed upon; provided
      further
      that
      Section 6 of this Agreement shall continue in full force and effect during
      any
      period in which you are consulting with the Company, including without
      limitation, any period of consulting following the Term and shall survive the
      termination of your consulting.

    

    (a)
      Termination
      Without Cause.
      During
      the Term, this Agreement and the Consultant’s services may be terminated by
      either party without Cause by giving thirty (30) days’ prior written notice of
      such termination to the other party; provided,
      however,
      that
      the Company may terminate the consultancy without any payment obligation
      immediately after receiving written notice that the Provider intends to
      terminate this Agreement. In the event that the Company terminates the
      Consultant’s services without Cause during the Term, the Company shall, subject
      to the Consultant’s execution and delivery of a general release in favor of the
      Company and its affiliates, and the Provider’s and Consultant’s compliance with
      the terms of this Agreement, pay a severance payment of the greater of the
      remaining payments due on the term of this Agreement or an Annual Base Salary
      otherwise payable through one (1) year, payable in accordance with the Company’s
      normal payroll practices (or, at the Consultant’s option, in one lump sum
      payment, discounted to present value using a 5% discount rate), and
      notwithstanding anything to the contrary, the Consultant will be entitled to
      such payments only if the Consultant and Provider have complied in full with
      the
      terms of this Agreement following his termination (e.g.,
      his
      Non-Competition, Non-Solicitation, Confidentiality, and Return of Property
      obligations, etc.).
      In
      addition, (i) the Consultant shall be entitled to receive all earned but unpaid
      amounts due under Section 3 (which shall become due and payable on the date
      of
      termination) and (ii) any of the Consultant’s unvested options issued pursuant
      to the Company’s Stock Option Plan, bonuses and other compensation shall vest on
      the date of termination.

    

    (b) Termination
      with Cause.
      The
      Provider and Consultant understand and agrees that the Company reserves the
      right to terminate this Agreement for Cause upon thirty (30) days prior written
      notice to the Provider. Upon termination for Cause, the Company shall pay the
      Provider any accrued but unpaid compensation owing as of the termination date,
      and the Consultant will deliver to the Company all of the work that he has
      prepared to date for the Company and return any property belonging to the
      Company. The Consultant acknowledges that his obligations under Section6, will
      survive the termination or expiration of this Agreement. 

    

    For
      the
      purposes of this Section 5, “Cause”
shall
      mean Consultant’s:

     

    
      	 	
              (i)

            	
              failure
                or refusal to perform, or any misconduct in the performance of, any
                significant portion of his obligations, duties and responsibilities
                under
                this Agreement, which (A) is incapable of cure or (B) has not been
                cured
                or remedied as promptly as is reasonably possible (and in any event
                within
                forty-five (45) days) after written notice from the Company to the
                Consultant specifying in reasonable detail the nature of such failure,
                refusal or misconduct; or

            

    

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    
      	 	
              (ii)

            	
              material
                breach of the provisions of Sections 6, of this Agreement which (A)
                is
                incapable of cure or (B) has not been cured or remedied promptly
                (and in
                any event within forty-five (45) days) after written notice from
                the
                Company to the Consultant specifying in reasonable detail the nature
                of
                such breach; or

            

    

     

    
      	 	
              (iii)

            	
              act
                or acts of dishonesty in connection with his employment;
                or

            

    

     

    
      	 	
              (iv)

            	
              commission
                of a felony or other crime which materially and adversely affects
                the
                Company or its business or
                reputation.

            

    

     

    6.
      Restrictions.
      The
      Provider and Consultant acknowledge that the business in which the Company
      is
      engaged is highly competitive and that as a result of the Consultant’s position
      within DRG and the Company, he has acquired and will acquire extensive
      confidential information and knowledge of the business of the Company, and
      will
      develop relationships with, and/or knowledge of, customers, clients, employees,
      sales agents, middlemen and suppliers of the Company and its subsidiaries and
      affiliates. In light of the foregoing, the Provider and the Consultant agree
      as
      follows:

    

    6.1
      Nonsolicitation.
      While
      Consultant is performing Services hereunder and for a period of eighteen (18)
      months thereafter, he agrees that he will not, either directly or indirectly,
      (a) attempt to recruit, solicit or take away any employee or consultant of
      Company; make known to any person, firm or corporation the names or addresses
      of, or any information pertaining to any employee or consultant of Company
      or
      (b) attempt to call on, solicit or take away any customer or collaborating
      partner of Company or any prospective customer or collaborating partner whose
      identity as such was learned by him during the performance of the Services
      hereunder.

    

    6.2.
      Non-competition.
      While
      the Consultant is performing the Services and for a period of eighteen (18)
      months thereafter, (a) he will not directly or indirectly be interested in,
      as
      an owner, partner, member or shareholder of any entity, which engages in
      activities related to debt reduction, financial website portals or any other
      activity that is specific to the business of the Company and its affiliates
      from
      time to time (“Proscribed
      Activity”)
      provided,
      however,
      that
      the Consultant and members of his family may acquire (or hold) solely for
      investment purposes up to 5% of the outstanding equity interests in any
      publicly-traded company; and (b) the Consultant will not, directly or indirectly
      as an employee, officer, director, partner, joint venturer, consultant or
      otherwise engage in any Proscribed Activity or participate, consult with, render
      services to or permit his name to be used or any other manner or capacity engage
      in any business or enterprise which engages in Proscribed Activity.

    

    6.3
      No
      Recruiting.
      While
      the Consultant is performing the Services and for a period of eighteen (18)
      months thereafter, the Consultant will not, directly or indirectly, on his
      own
      behalf or as an owner, partner, officer, director, employee or consultant of
      any
      entity, hire or offer to hire any person who is or was an employee or contractor
      or collaborating partner of the Company. Notwithstanding anything to the
      contrary above, if during the period that this provision is effective, the
      Consultant and Damon Stein are no longer employed by the Company, they may
      collaborate on other business endeavors which do not compete with the Company’s
      business.

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    6.4
      Confidentiality.
      

    

    (a)
      The
      Provider and the Consultant agree at all times during performance of the
      Services for the Company and thereafter to hold in strictest confidence, and
      not
      to use, except for the benefit of the Company and within the scope of the
      Services for the Company, or to disclose (except as required by law) to any
      person or entity, any Confidential Information of the Company. “Confidential
      Information”
means
      (i) any and all information,
      in
      whatever form, whether reduced to writing, maintained on any form of electronic
      media, or maintained in mind or memory, received
      by the Provider or the Provider or the Consultant or generated by the Consultant
      on behalf of the Company at any time before or after the date of this Agreement
      relating
      to the current or prospective business, research and development activities,
      products, technology, strategy, organization and/or finances of the Company,
      or
      of third parties (including affiliates, vendors, suppliers and customers) with
      which the Company has a business relationship and (ii) any other information,
      in
      whatever form, designated by the Company as confidential, in either of cases
      (i)
      or (ii), above, whether disclosed to, or obtained by the Provider or the
      Consultant prior or subsequent to the date of execution of this Agreement.
      Confidential Information shall include
      without limitation customer lists, database information, samples, demonstration
      models or materials and other embodiments of products or prospective products,
      software and other technology, projections, existing and proposed projects
      or
      experiments, processes
      and methodologies and trade secrets and all Developments, as defined below,
      but
      excluding (A) information that the Company deliberately and voluntarily makes
      publicly available and (B) information
      disclosed by the Provider or the Consultant to comply with a court, or other
      lawful compulsory order compelling him to do so, provided he gives the Company
      prompt notice of the receipt of such order and disclosure is limited only to
      disclosure necessary for such purpose. The
      Provider and Consultant specifically acknowledges that the Confidential
      Information derives independent economic value from not being readily known
      to,
      or ascertainable by proper means by, others; that the Company has expended
      considerable sums and efforts to develop such Confidential Information;
      reasonable efforts have been made by the Company to maintain the secrecy of
      such
      information; that such information is the sole property of the Company or its
      affiliates, vendors, suppliers, or customers and that any retention, use or
      disclosure of such Confidential Information by the Provider or the Consultant
      during the Term (except in the course of performing the Services) or any time
      after termination thereof for any reason, shall constitute a violation of this
      Agreement and the misappropriation of the trade secrets and Confidential
      Information of the Company or its affiliates, vendors, suppliers, or
      customers. 

    

    (b)
      The
      Provider and the Consultant recognize that the Company has received and in
      the
      future will receive Confidential Information of and from other companies subject
      to a duty on the Company’s part to maintain the confidentiality of such
      information and to use it only for certain limited purposes. The Provider and
      the Consultant agree to hold all such confidential or proprietary information
      in
      the strictest confidence and not to disclose it to any person or entity or
      to
      use it except as necessary in performing the Services.

    

    (c)
      The
      Provider and the Consultant agree that all Confidential Information, in any
      form, shall be and remain the sole and exclusive property of the Company and
      that immediately upon the termination of the Term, or at any other time that
      the
      Company may request, the Consultant will deliver all Confidential Information
      in
      his control to the Company or, if instructed to do so by the Company, the
      Consultant will delete or destroy all Confidential Information in his
      control.

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    6.5.
      Assignment
      of Work Product.

    

    (a)
      If at
      any time during the performance of the Services for the Company, the Consultant
      has or shall (either alone or with others) make, conceive, create, discover,
      invent or reduce to practice any invention, design, development, improvement,
      process, software program, work of authorship, or technique, in
      whole
      or in part, or which results from any work which he may do for or at the request
      of the Company, whether or not conceived by him while on holiday, on vacation,
      or off the premises of the Company, including such of the foregoing items
      conceived during the course of his consultancy which are developed or perfected
      after his termination date,
      whether
      or not patentable or registrable under copyright or similar statutes (herein
      called “Developments”)
      that
      (i) relates to the business of the Company or any of the products or services
      being developed, manufactured or sold by the Company, or (ii) results directly
      or indirectly from tasks assigned him by the Company or (iii) results from
      the
      use of premises or property (whether tangible or intangible) owned, leased
      or
      contracted for by the Company, the Consultant shall promptly disclose to the
      Company each such Development and the Company shall have a first right of
      refusal on whether it wants such Development and all rights and interests
      therein (the “Right
      of First Refusal”).
      The
      Company may exercise this right by (i) confirming its interests in the
      Development in writing to the Consultant within 90 days of Consultant presenting
      such Development to Company and (ii) including a plan to implement the
      Development within a fixed time frame (the “Development
      Plan”).
      

    

    (b)
      If
      the Company exercises its right of first refusal then all records relating
      to
      such Developments shall be the sole and absolute property of the Company. At
      such time, the Consultant shall deliver to the Company all records relating
      to
      each such Development; and will assign any rights (including, but not limited
      to, any rights under patent law and copyright law or other similar laws) the
      Consultant may have or acquire in the Developments to the Company, without
      further compensation. To
      the
      extent any work of authorship to which the Company has exercised the Right
      of
      First Refusal may not be deemed to be a work made for hire, the Consultant
      agrees to irrevocably, perpetually and unconditionally transfer and assign
      to
      the Company all right, title, and interest including copyright in and to such
      work without further compensation. 

    

    (c)
      With
      respect to any Development for which the Company has exercised its Right of
      First Refusal, the Consultant will, during the Term and at any time thereafter,
      at the request and cost of the Company, promptly sign all such assignments,
      applications and other documents, and take such other actions, as the Company
      and its duly authorized agents may reasonably require: (i) to evidence the
      Company’s ownership of any Development and to apply for, obtain, register and
      vest in the name of the Company, or renew, patents, copyrights, trademarks
      or
      other similar protection for any Development in any country throughout the
      world
      and (ii) to initiate or defend any judicial, administrative or other proceedings
      in respect of such patents, copyrights, trademarks or other similar
      rights.

    

    (d)
      In
      the event the Company is unable, after reasonable effort, to secure the
      Consultant’s signature for such purposes for any reason whatsoever, the
      Consultant hereby irrevocably designates and appoints the Company and its duly
      authorized officers and agents as his agents and attorneys-in-fact, to act
      for
      and in his name, behalf and stead, to execute and file any such assignments,
      applications or other documents and to do all other lawfully permitted acts
      to
      further the obtaining and protection of such patents, copyright or trademark
      registrations or other rights with the same legal force and effect as if
      executed by the Consultant. 

    

    (e)
      If
      Company declines interest, does not wish to pursue the Developments, or does
      not
      respond in writing to Consultant within the 90 day refusal period, then such
      Developments shall be the sole and absolute property of Consultant. If the
      Company fails within 6 months from the date it delivers a Development Plan
      to
      the Consultant to implement any part of such plan then all rights in such
      Development shall revert to the Consultant.

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    6.6.
       Prior
      Inventions.
      The
      Consultant does not have any pre-existing inventions that specifically relate
      to
      the Company’s business of debt reduction or financial portals. All inventions
      that the Consultant has made and owns, and all associated intellectual property
      rights, as of the Effective Date that relate to the Company’s business of debt
      reduction or financial portals shall be considered Developments and are subject
      to the terms hereof. 

    

    6.7
      Return
      of Property.
      At the
      expiration of the Term, or at any other time upon written request by the
      Company, the Consultant shall promptly deliver to the Company all records,
      files, memoranda, designs, data, reports, drawings, plans, computer programs,
      software and other documents (and all copies or reproductions for such materials
      in my possession or control) belonging to the Company, including, without
      limitation, all Developments and/or Confidential Information and anything
      relating thereto.

    

    6.8
      For
      the
      purposes of this Agreement, “Company” shall mean the Company and its
      subsidiaries and affiliates.

     

    7.
      General.

    

    7.1
      Independent
      Contractor.
      The
      Consultant understands that he is an independent contractor, not an employee
      of
      the Company, that he has no authority to enter into obligations on behalf of
      the
      Company except with the Company’s specific written approval, and that the
      Company is not responsible for withholding income, social security or other
      taxes from his compensation.

    

    7.2
      Remedies.
      The
      Provider and Consultant agree that any breach or threatened breach of Section
      6
      of this Agreement by him will cause irreparable damage to the Company; in
      addition to its other remedies at law or in equity the Company shall be entitled
      to injunctive or other equitable relief in order to prevent the violation of
      and
      to enforce my obligations under Section 6, without the posting of any
      bond.

    

    7.3
      No
      Obligation.
      The
      Consultant understands that this Agreement does not create an obligation on
      the
      Company or
      the
      Consultant
      or
any
      other
      person or entity to continue the Consultant’s engagement. 

    

    7.4
      Cooperation.
      During
      the Term and thereafter, the Provider and Consultant agrees to fully cooperate
      with the Company or its counsel in connection with any matter, investigation,
      proceeding or litigation regarding any matter in which the Consultant was
      involved during the Term or to which the Consultant had knowledge based on
      his
      provision of the Services to the Company.

    

    7.5
      Notices.
      Any
      notice or any other communication required or permitted to be given hereunder
      shall be in writing and shall be sufficiently given (a) when delivered by
      personal delivery; or (b) two days after sending by registered mail,
      postage prepaid, return receipt requested, to
      the
      party entitled thereto at the address stated below.

    

    (a)          
      To
      the
      Company:

    6477
      HWY
      93 South

    Suite
      303

    Whitefish,
      MT 59937

    Attn:
      Brian Ross

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    (b)         
      To
      the
      Consultant:

    206
      East
      Patcong Ave.

    Linwood,
      NJ 08221

    and

    313
      Anita
      Street #B

    Redondo
      Beach, CA 90278

    

    7.6
      No
      Conflict.
      The
      Provider and the Consultant represent that the performance of all of the terms
      of this Agreement does not and will not conflict with or breach any agreement
      the Provider or Consultant has with any other party.

    

    7.7
      Waivers.
      Any
      waiver by the Company of any provision of this Agreement shall not operate
      or be
      construed as a waiver of any subsequent breach of such provision or any other
      provision. 

    

    7.8
      Scope
      of Restrictions.
      The
      Provider hereby agrees that the unenforceability of any one clause of this
      Agreement shall in no way impair the enforceability of any of the other clauses.
      If any of the provisions of this Agreement shall for any reason be held to
      be
      excessively broad as to scope, activity, subject or otherwise, the parties
      hereto agree that such provisions shall be construed by the appropriate judicial
      body by limiting or reducing them, so as to be enforceable to the maximum extent
      legally permissible.

    

    7.9
      Survival
      of Terms.
      The
      Provider and the Consultant’s obligations under Sections 6 and 7 of this
      Agreement shall survive the termination of this Agreement for any reason
      whatsoever regardless of the manner of such termination and shall be binding
      upon their heirs, executors, administrators and legal
      representatives.

    

    7.10
      Successors
      and Assigns.
      This
      Agreement shall inure to the benefit of and be enforceable by the Company’s
      successors or assigns. The
      Company shall have the right to assign this Agreement.

    

    7.11
      Governing
      Law.
      This
      Agreement shall be governed by and construed in accordance with the laws of
      the
      State of Delaware without regard to its conflict of law provisions.

    

    7.12 Dispute
      Resolution

    

    (a)
      Hierarchy
      of Dispute Resolution Procedures.
      Any
      dispute, controversy, or claim, whether based on contract, tort, statute, fraud,
      misrepresentations, or any other legal theory between the Company, on the one
      hand, and you, on the other hand (a “Dispute”),
      that
      arises out of or relates to this Agreement or any obligations or related
      services to be provided under this Agreement, shall be resolved in accordance
      with the procedures described in this Section 7.12. In the case of a Dispute,
      the parties shall establish an internal hierarchy to facilitate resolution
      of
      any Dispute as set forth below:

     

    (i)
      Upon
      written request of the Company or you , the Company shall appoint one designated
      representative and you shall either represent yourself or appoint one designated
      representative whose task it shall be to meet for the purpose of endeavoring
      to
      resolve such Dispute. Before any initial meeting, the designated representative
      shall provide to each party written notice of any Dispute, which notice shall
      include a detailed description of the claim or dispute sufficient to allow
      a
      full analysis and complete response. Each party shall exercise good faith in
      providing its response to any claim or dispute, in advance of the first meeting
      between designated representatives. The designated representatives shall meet
      as
      often as the parties reasonably deem necessary to discuss the Dispute in an
      effort to resolve the Dispute without the necessity of any further
      proceeding.

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    (ii)
      The
      Company and you shall negotiate in good faith in an attempt to resolve the
      Dispute for a period of not greater than sixty (60) days after notice of the
      Dispute is received by the parties.

    

    (b)
      Arbitration

     

    (i)
      If
      the parties are unable to resolve any Dispute as contemplated by Section
      7.12(a), such Dispute, excluding any matter relating to questions of
      arbitrability and any action for injunctive relief or specific performance,
      shall be submitted to arbitration.

     

    (ii)
      Any
      arbitration hereunder shall be conducted as a self administered arbitration
      in
      accordance with and subject to the Federal Arbitration Act (9 U.S.C. § 1 et
      seq., the “Arbitration
      Act”)
      to the
      exclusion of any state arbitration laws, and to the extent not inconsistent
      with
      the Arbitration Act, in accordance with the commercial arbitration rules of
      the
      American Arbitration Association, as then in effect (the “Arbitration
      Rules”).
      The
      arbitration shall occur in New York, NY.

     

    (iii)
      The
      arbitration panel shall consist of one(1) arbitrator, chosen by mutual agreement
      of the parties. The arbitrators shall be a lawyer, judge or mediator experienced
      in the resolution of commercial disputes. The relevant parties shall cooperate
      to select the arbitrator promptly after service of a document initiating
      arbitration.

     

    (iv)
      The
      award of an arbitrator shall be final and binding upon the parties to such
      arbitration proceeding, with only such rights of appeal or review as are
      available under the Arbitration Act.

     

    (v)
      Except for the matters specifically addressed in the Arbitration Rules or
      hereafter in this 7.12(b) the procedural rules for the conduct of an arbitration
      under this Section 7.12(b) shall be established by the arbitrator consistent
      with the parties' intent that any arbitration hereunder is to be conducted
      in a
      streamlined and expedited manner, with limited discovery, and as economically
      as
      practicable. In addition, the following shall apply:

     

    (A)
      All
      costs and fees of counsel and expert witnesses shall be borne by the party
      incurring the same; and

     

    (B)
      The
      costs of the arbitrator shall be divided equally among the parties to any
      arbitration proceeding.

     

    7.13
      Entire
      Agreement; Amendment.
      This
      Agreement constitutes the entire agreement between the Company and the Provider
      with respect to the subject matter hereof (except with respect to the NSO),
      and
      supersedes all prior discussions, promises, negotiations and agreements (whether
      written or oral). The parties agree that the NSO Agreement governs the terms
      of
      the NSO and if any provision of this Agreement conflict with the terms of the
      NSO Agreement, the terms of the NSO Agreement shall govern. This Agreement
      may
      be amended or modified only by a written agreement executed by the Company
      and
      the Consultant.

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    7.14
      Tax
      Withholding.
      The
      Company may withhold from any amounts payable under this Agreement or otherwise
      all federal, state, city, or other taxes as may be required pursuant to any
      law
      or governmental regulation or ruling.

    

    7.15
      During
      the Term or any extension thereof pursuant to Section 5, the Consultant shall
      have the right to require the Company to amend the non-qualified stock option
      issued by the Company to the Consultant of even date herewith so that it mirrors
      any option granted to Brian Ross after the date hereof in all material respects
      except as to the number of options granted; provided
      however
      that the
      Consultant understands and agrees that he is not eligible for and may not
      receive an Incentive Stock Option under the Company's Stock Option Plan even
      if
      one is awarded to Mr. Ross.

     

    

    [SIGNATURE
      PAGE FOLLOWS]

    

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

    

    IN
      WITNESS WHEREOF,
      I have
      executed this Agreement,
      effective as of the
      Effective Date,
      as a
      sealed instrument on this 1st day of January,
      2007.

    

    PROVIDER:
      

    Facility
      Consulting, LLC

    

    

    By:  /s/
      Dan Goldberg            

    Title:
      Manager

    Name:
      Dan
      Goldberg

    

    

    

    ACCEPTED:
      ACCELERIZE NEW MEDIA, INC.

    

    By:  /s/
      Brian Ross                

    Brian
      Ross

    Title: 
      President

    

    

    ACKNOWLEDGED:
      CONSULTANT

    

    

    

    /s/
      Dan Goldberg                

    Daniel
      Goldberg

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

    Exhibit
      A

    

    [insert
      description of BCBS plan or attach copy of a bill with relevant
      information]

     

    
 

    

    11QuickLinks
 -- Click here to rapidly navigate through this document
  

 
 

Exhibit 4.5    
    

AMENDMENT NO. 1

TO THE

AGREEMENT AND PLAN OF MERGER  

        This AMENDMENT NO. 1 (this "AMENDMENT"), dated as of April 3, 2006, to the Agreement and Plan of Merger, dated as of October 30, 2005 (the "MERGER
AGREEMENT"), by and among Novartis Corporation, a New York corporation and an indirect wholly owned subsidiary of Novartis AG ("Parent"), a Swiss corporation ("NOVARTIS CORP"), Novartis Biotech
Partnership, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent AG ("MERGER Sub"), Chiron Corporation, a Delaware corporation ("CHIRON"), and for purposes of Section
10.14 thereof only, Parent. 

        WHEREAS,
Section 10.2 of the Merger Agreement provides for the amendment of the Merger Agreement in accordance with the terms set forth therein; and 

        WHEREAS,
the parties hereto desire to amend the Merger Agreement as set forth below; 

        NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, and intending to be legally bound hereby, the parties hereto do hereby agree as follows: 

ARTICLE I

DEFINITIONS  

        Section 1.1    DEFINITIONS; REFERENCES.    Unless otherwise specifically defined herein, each term used herein shall have the meaning
assigned to such term in the Merger Agreement. Each reference to "hereof," "herein," "hereunder," "hereby" and "this Agreement" shall, from and after the date hereof, refer to the Merger Agreement as
amended by this Amendment. 

ARTICLE II

AMENDMENTS TO MERGER AGREEMENT  

        Section 2.1    AMENDMENTS TO MERGER AGREEMENT.    The Merger Agreement shall be amended as follows: 

	(a)
	SECTION
4.1(a) of the Merger Agreement is hereby amended by deleting clause (i) in its entirety and inserting the following in its place:

	"(i)
	owned
by Merger Sub or any other U.S. Subsidiary of Parent"

	(b)
	SECTION
4.1(a) is hereby further amended by deleting "$45.00" and replacing such amount with "$48.00".

	(c)
	SECTION
4.1(b) of the Merger Agreement is hereby amended by deleting the words "by any of the Novartis Companies" and replacing such words with: 

"by
Merger Sub or any other U.S. Subsidiary of Parent" 

	(d)
	SECTION
5.3(b) of the Merger Agreement is hereby amended by inserting the following sentence at the end of such Section: 

"For
purposes of this Agreement, "Novartis Companies" shall mean, collectively, Parent and any direct or indirect Subsidiary of Parent." 

1

 

	(e)
	SECTION
7.2(a) is hereby amended by deleting the word "conditions" from clause (y) of the second sentence of such Section and replacing such word with "condition" and by
replacing the word "have" with the word "has.

	(f)
	SECTION
7.3(a) is hereby amended by deleting the word "conditions" from the first sentence of such Section and replacing such word with "condition".

	(g)
	SECTION
8.1(a) if the Merger Agreement is hereby amended by deleting such Section in its entirety and by inserting the following in its place: 

"(a)
STOCKHOLDER APPROVAL. This Agreement shall have been duly adopted by holders of shares of Common Stock constituting the Company Requisite Vote in accordance with applicable Law and the Company's
certificate of incorporation and by-laws." 

	(h)
	Annex
A is hereby amended to reflect the change in location of the defined term "Novartis Companies" from Section 4.1(a) to Section 5.3(b).

	(i)
	The
parties agree that the Stockholders Meeting shall be postponed or adjourned until April 19, 2006, or such other date as the parties may agree. 

ARTICLE III

MISCELLANEOUS  

        Section 3.1    NO FURTHER AMENDMENT.    Except as expressly amended hereby, the Merger Agreement is in all respects ratified and
confirmed and all the terms, conditions, and provisions thereof shall remain in full force and effect. This Amendment is limited precisely as written and shall not be deemed to be an amendment to any
other term or condition of the Merger Agreement or any of the documents referred to therein. 

        Section 3.2    EFFECT
OF AMENDMENT.    This Amendment shall form a part of the Merger Agreement for all purposes, and each party thereto and hereto
shall be bound hereby. From and after the execution of this Amendment by the parties hereto, any reference to the Merger Agreement shall be deemed a reference to the Merger Agreement as amended
hereby. 

        Section 3.3    GOVERNING
LAW.    This Amendment shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the
laws that might otherwise govern under applicable principles of conflict of laws. 

        Section 3.4    SEPARABILITY
CLAUSE.    In case any one or more of the provisions contained in this Amendment should be invalid, illegal or unenforceable in any
respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be affected, impaired, prejudiced or disturbed thereby. 

        Section 3.5    COUNTERPARTS.    This
Amendment may be simultaneously executed in several counterparts, and all such counterparts executed and delivered, each
as an original, shall constitute one and the same instrument. 

        Section 3.6    HEADINGS.    The
descriptive headings of the several Articles of this Amendment were formulated, used and inserted in this Amendment for
convenience only and shall not be deemed to affect the meaning or construction of any of the provisions hereof. 

2

 

        IN
WITNESS WHEREOF, Novartis Corp, Merger Sub, and Chiron have caused this Amendment to be signed by their respective officers thereunto duly authorized, all as of the date first written
above. 

	 	 	NOVARTIS CORPORATION
	

 	
 	
By:	

/s/  GEORGE MILLER      
 George Miller
 General Counsel

       

	 	 	NOVARTIS BIOTECH PARTNERSHIP. INC.
	

 	
 	
By:	

/s/  WAYNE P. MERKELSON      
 Wayne P. Merkelson
 Vice President

       

	 	 	CHIRON CORPORATION
	

 	
 	
By:	

/s/  HOWARD PIEN      
 Howard Pien
 Chief Executive Officer

3

QuickLinks

Exhibit 4.5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}]]